The antidepressant drug vilazodone is an allosteric inhibitor of the serotonin transporter
Vilazodone (VLZ) is a drug for the treatment of major depressive disorders that targets the serotonin transporter (SERT). Here, the authors combine pharmacology measurements and cryo-EM structural analysis to characterize VLZ binding to SERT and observe that VLZ exhibits non-competitive inhibition o...
Main Authors: | Per Plenge, Dongxue Yang, Kristine Salomon, Louise Laursen, Iris E. Kalenderoglou, Amy H. Newman, Eric Gouaux, Jonathan A. Coleman, Claus J. Loland |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-08-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-021-25363-3 |
Similar Items
-
The mechanism of a high-affinity allosteric inhibitor of the serotonin transporter
by: Per Plenge, et al.
Published: (2020-03-01) -
Thermostabilization of the Human Serotonin Transporter in an Antidepressant-Bound Conformation.
by: Evan M Green, et al.
Published: (2015-01-01) -
The role of new antidepressants in clinical practice in Canada: a brief review of vortioxetine, levomilnacipran ER, and vilazodone
by: McIntyre RS
Published: (2017-11-01) -
Crystal structure of vilazodone hydrochloride methanol monosolvate
by: Xiu-Rong Hu, et al.
Published: (2016-12-01) -
Suicide attempt with selective serotonin reuptake inhibitor antidepressants
by: Sandra Cuenca Carcelén, et al.
Published: (2021-01-01)